Proteomics Service
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 75N95025Q00234
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, has issued a Sources Sought notice for proteomics services to support research into alcohol and drug addiction mechanisms. The agency seeks vendors capable of providing proteomic mouse panel analysis services encompassing a minimum of 120 proteins, targeting key pathways in inflammation, neurodegeneration, and oncogenesis, with the ability to detect low abundant targets such as p-tau217. The services must cover immunology and neurology content, identify potential therapeutic targets, and perform ultra-high sensitivity multiplexed analysis for biomarker profiling and validation. Interested vendors must submit capability statements addressing each requirement separately, including company information, NAICS codes, business size and status, and technical qualifications. All responses must be submitted electronically to Contract Specialist Shaun Rostad at Shaun.Rostad@nih.gov by 1:00 p.m. EST on August 11, 2025, with the Sources Sought number and organization name in the subject line.
This opportunity does not utilize any set-aside designation and no incumbent contractors are identified in the notice. The specific requirement is for five units of the "NULISAseq Mouse Panel 120 Service" (No. 901044), which appears to be the brand name or equivalent service being sought. No budget range or award values are disclosed in this pre-solicitation notice. The notice emphasizes this is strictly for market research purposes and will not result in any contract awards, with the government reserving the right to use submitted information for planning future acquisitions. The opportunity falls under NAICS code 541380 (Testing Laboratories and Services) and PSC code Q301 (Reference Laboratory Testing), indicating the specialized nature of the laboratory services required.
Notice text
DESCRIPTION:
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to provide equipment for this requirement.
This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only.
BACKGROUND INFORMATION AND OBJECTIVE:
The Neurobiology of Addiction Section goal is to understand the underlying biological mechanisms of alcohol and drugs of abuse dependence to search for better therapies for the treatment of these patients. We have specialized and complex animal models to study these disorders in parallel with samples from clinical trials of close collaborator laboratories. The ability to run these assays in clinical samples in parallel with our animal models would increase the impact and translatability of our findings.
GENERIC NAME OF SERVICE:
Proteomic Mouse Panel Analysis for the Investigation of Potential Biomarkers
SALIENT CHARACTERISTICS:
Capable vendors must demonstrate their ability to provide the following brand name or equal services:
- Must Encompass a minimum of 120 proteins.
- Must be able to target key pathways involved in inflammation, neurodegeneration and oncogenesis.
- Must be able to detect key low abundant targets such as p-tau217.
- Must cover immunology and neurology content.
- Must be able to identify potential therapeutic targets.
- Must perform ultra-high sensitivity and multiplexed analysis to support broad biomarker profiling and validation.
QUANTITY: (Brand name or equal)
- NULISAseq Mouse Panel 120 Service: No. 901044. Qty. 5
INSTRUCTIONS:
Companies that believe they possess the capabilities to provide the required services should submit documentation of their ability to meet each of the requirements to the Contracting Officer. The capability statement must specifically address each of the requirements separately. All capability statements must also include the following: 1) company name and address; 2) point of contact; 3) phone/fax/email; 4) NAICS Code(s); 5) business size and status; 6) capability information in response to the requirement and qualifications identified in this notice; and 7) type of small business your organization classifies itself as (i.e.: Women-Owned, HUBZone, etc.).
Each capability statement must include the respondent’s Unique Entity Identifier number, organization name, and address. Each response should include the technical and administrative points of contact, including names, titles, addresses, telephone numbers, and e-mail addresses. The capability statement should clearly identify the size and type of business (e.g., 8(a), HubZone, Non-Profit, Other Than Small Business, etc.), pursuant to the applicable NAICS code and any other information that may be helpful in developing or finalizing the acquisition requirements.
The information submitted must be in an outline format that addresses each of the elements of the project requirement and in the capability statement paragraphs stated herein. A cover page and an executive summary may be included but is not required.
Any business concerns that believe they possess the capability necessary to successfully undertake the work described above must SUBMIT CAPABILITY STATEMENTS ELECTRONICALLY to the Contract Specialist, Shaun Rostad at Shaun.Rostad@nih.gov, NO LATER THAN 1:00 p.m. EST on August 11, 2025. The Subject line for the submission should include this Sources Sought Number and organization name. NIDA will not accept paper or faxed capability statements.
THIS NOTICE IS NOT A REQUEST FOR PROPOSALS. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation.
CONFIDENTIALITY. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
Notice history
| Notice | Type | Posted |
|---|---|---|
| Proteomics Service | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity